Opiate Crisis

Dental Opioid Prescriptions Increased During COVID-19, Pausing Trends in Reduction

A recent cross-sectional analysis of IQVIA Longitudinal Prescription Data reveals a concerning increase in dental opioid prescribing during the COVID-19 pandemic. The study, covering the period from 2016 to 2022, initially showed a 45% decrease in dental opioid prescriptions. However, during the pandemic, this positive trend slowed, with a 31.4% surge in dental opioid dispensing […]

Dental Opioid Prescriptions Increased During COVID-19, Pausing Trends in Reduction Read More »

New Study: 4th Wave Of Opiate Crisis Skyrockets

A recent study published in Addiction examined polysubstance overdose deaths in the United States during the transition to the fourth wave of the drug overdose crisis. The researchers analyzed national death records from 2010 to 2021 and found an over 50 fold increase in overdose deaths involving both fentanyl and stimulants, with the most substantial

New Study: 4th Wave Of Opiate Crisis Skyrockets Read More »

Is Wastewater Sampling The New Dumpster Diving?

Researchers from Boston College, Boston University, and Giner Labs have developed a groundbreaking penny-sized biosensor using atom-thick graphene. This innovative device, described in ACS Nano, is the first to utilize graphene-based field effect transistors for detecting four different opioids simultaneously in wastewater, addressing a key challenge in understanding opioid usage within communities. When an opioid

Is Wastewater Sampling The New Dumpster Diving? Read More »

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners Read More »

FDA Approves OTC Naloxone

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA

FDA Approves OTC Naloxone Read More »

Shopping Cart
Scroll to Top